Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T68698 | ||||
Target Name | Adenosylhomocysteinase (AHCY) | ||||
Type of Target |
Literature-reported |
||||
Drug Potency against Target | Drug Info | IC50 = 30 nM | [5] | ||
5'-deoxy-5'-ureidoadenosine | Drug Info | IC50 = 7530 nM | [2] | ||
5-methylenearisteromycin | Drug Info | IC50 = 15700 nM | [3] | ||
ARISTEROMYCIN | Drug Info | IC50 = 4850 nM | [3] | ||
FLUORO-NEPLANOCIN A | Drug Info | IC50 = 480 nM | [1] | ||
NORARISTEROMYCIN | Drug Info | IC50 = 3100 nM | [4] | ||
References | |||||
REF 1 | Synthesis of 5'-substituted fluoro-neplanocin A analogues: importance of a hydrogen bonding donor at 5'-position for the inhibitory activity of S-a... Bioorg Med Chem Lett. 2004 Nov 15;14(22):5641-4. | ||||
REF 2 | Design, synthesis, and molecular modeling studies of 5'-deoxy-5'-ureidoadenosine: 5'-ureido group as multiple hydrogen bonding donor in the active ... Bioorg Med Chem Lett. 2007 Aug 15;17(16):4456-9. | ||||
REF 3 | Synthesis of 2-modified aristeromycins and their analogs as potent inhibitors against Plasmodium falciparum S-adenosyl-L-homocysteine hydrolase. Bioorg Med Chem. 2008 Apr 1;16(7):3809-15. | ||||
REF 4 | Synthesis of 4'-modified noraristeromycins to clarify the effect of the 4'-hydroxyl groups for inhibitory activity against S-adenosyl-L-homocystein... Bioorg Med Chem Lett. 2008 Apr 15;18(8):2615-8. | ||||
REF 5 | A new structural class of S-adenosylhomocysteine hydrolase inhibitors. Bioorg Med Chem. 2009 Sep 15;17(18):6707-14. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.